118000 — Metacare Co Income Statement
0.000.00%
- KR₩41bn
- KR₩100bn
- KR₩33bn
Annual income statement for Metacare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18,613 | 19,098 | 17,257 | 20,208 | 32,822 |
| Cost of Revenue | |||||
| Gross Profit | 5,096 | 6,517 | 6,528 | 7,672 | 10,003 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 26,535 | 17,788 | 16,301 | 13,145 | 32,239 |
| Operating Profit | -7,921 | 1,310 | 956 | 7,063 | 583 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 7,497 | -49,555 | -4,543 | 1,895 | -205 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9,856 | -49,555 | -4,547 | 1,895 | -212 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 7,740 | -49,555 | -14,540 | 8,497 | 498 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7,740 | -49,555 | -14,540 | 8,497 | 498 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 212 | -611 | 45.8 | -24.2 | 6.75 |
| Dividends per Share |